by John Conrad | Feb 16, 2023 | Member News
CHICAGO (PRWEB) FEBRUARY 01, 2023 Dimension Inx, a biomaterials platform company, announced today that they have closed a $12M Series A Round. The round was led by Prime Movers Lab (PML), with participation by returning investors KdT Ventures and Revolution’s Rise of...
by John Conrad | Feb 16, 2023 | Member News
FlowSense shunt monitor quickly and non-invasively detects the flow of cerebrospinal fluid in implanted shunts, addressing a significant unmet need in hydrocephalus patient management EVANSTON, Ill., Feb. 16, 2023 /PRNewswire/ — Rhaeos®, Inc. (Rhaeos), a...
by John Conrad | Jan 27, 2023 | Member News
CHICAGO–(BUSINESS WIRE)–ClostraBio, a biotech company focused on developing novel therapeutic solutions for diseases of the gut, is excited to announce a major breakthrough in targeted metabolite delivery to transform intestinal health. This...
by John Conrad | Jan 19, 2023 | Member News
As Horizon ties up the loose ends for its $28 billion sale to Amgen, a drug it picked up from a previous acquisition of its own is delivering a mid-stage win. Horizon had already declared Phase II success for dazodalibep among one group of patients with Sjögren’s...
by John Conrad | Jan 12, 2023 | Member News
In the wake of Evozyne’s hiring of a seasoned tech-company executive as CEO, the Chicago-based biotech company announced it’s developed an AI model that it hopes will revolutionize development of new therapeutic proteins, significantly accelerating the...
